Open Access Publisher and Free Library
CRIME+CRIMINOLOGY.jpeg

CRIME

Violent-Non-Violent-Cyber-Global-Organized-Environmental-Policing-Crime Prevention-Victimization

Posts tagged Trends
SELECTING AND VALIDATING OUTCOME MEASURES FOR THE DOMESTIC VIOLENCE AND ABUSE CORE OUTCOME SET (DVA-COS) 

By Jenna Harewell, Elizabeth Dunk Shivi Bains, Emma Howarth, Claire Powell, Lazaros Gonidis

  Background - The domestic abuse core outcome set (DVA-COS) is an agreed set of five outcomes intended for use in evaluations of interventions or services for children and families with experience of domestic violence and abuse (DVA, hereafter referred to as domestic abuse). A COS is a minimum standard for measurement in intervention studies, the purpose of which is to overcome heterogeneity in outcome selection and measurement. The aim of a COS is to maximise the value of a body of evidence by facilitating comparison between and synthesis across studies, thus reducing research wastage. Since the development of the DVA-COS, work has been undertaken to identify, select, and validate outcome measurement instruments (OMIs) to measure the core outcomes. The Warwick– Edinburgh Mental Wellbeing Scale (WEMWBS) was previously identified as acceptable by stakeholders to capture two outcomes: child and caregiver emotional health and wellbeing. This work seeks to extend those findings by validating the measure for use with domestic abuse experienced populations. Aims Foundations, the national What Works Centre for Children & Families, commissioned two work packages to develop and integrate previous work to outline and validate OMIs for use to assess outcomes comprising the DVA-COS. Work package 1 seeks to identify three OMIs, and this report focuses on work package 2, which aimed to validate the Short WEMWBS (SWEMWBS) for use with children and young people (aged 11 to 18) who have experienced domestic abuse. The studies that make up this work package used mixed methods to examine the acceptability, content validity, structural validity, internal consistency, and measurement invariance for the scale in children and young people experiencing domestic abuse. We also report a validation study of the WEMWBS for adults with experience of domestic abuse. Methods The above aims were addressed across four individual studies: two planned and two supplementary. First, a qualitative ‘think aloud’ study assessed the acceptability of the SWEMWBS with children and young people who had experienced domestic abuse. The remaining three studies were quantitative analyses of secondary data on using the SWEMWBS and WEMWBS with children and young people and adult samples. • Study A: a qualitative think aloud study that involved interviews and a focus group to gather feedback from children and young people with domestic abuse experience on use of the SWEMWBS. • Study B: examined cross-sectional data collected by the OxWell Student Survey to validate the SWEMWBS with children and young people affected by domestic abuse. • Study C: examined anonymised longitudinal service data to validate the SWEMWBS with children and young people affected by domestic abuse. • Study D: validated the WEMWBS with adults who have experienced domestic abuse using cross-sectional data from the Adult Psychiatric Morbidity Survey (APMS). Key findings Our findings demonstrate the validity and acceptability of the SWEMWBS and WEMWBS in domestic abuse-experienced child and adult populations respectively. Study A indicated that the SWEMWBS is broadly acceptable for use with children and young people, while raising important considerations regarding respondents’ interpretation of the measure’s items as well as the emotional impact of the measure on this population. Studies B and C demonstrated robust psychometric validity2 of the SWEMWBS with children and young people affected by domestic abuse, and Study D showed robust psychometric validity of the WEMWBS with adult victims of domestic abuse. These are significant findings given the limited number of measures that have been evaluated for use with this population across practice and research contexts. Moreover, this represents an important step forward in the implementation of the DVA-COS, which we hope will help to unify outcome measurement in domestic abuse research and evaluation, as well as service monitoring. Recommendations We recommend that the SWEMWBS and WEMWBS be used to measure wellbeing in the context of evaluation studies (of any quantitative design) seeking to assess the impact of child-focused domestic abuse interventions. To enhance the acceptability of the measure to children and adults we suggest minor adaptations for use in the domestic abuse context. Finally, we recommend the development of guidelines for practitioners and researchers about how to use the tools in a ‘carefirst’ way and how to guard against the tools being used for screening or triaging, or rationing care, as well as guidance for commissioners on how to interpret and use evidence, generated by the completion of the SWEMWBS and WEMWBS, for the basis of decision making. This guidance needs to reflect the balance between the benefits of data-driven decision making and the risk of unduly narrowing the breadth of services or thwarting innovation in the sector. The OMI’s implementation (including the use of guidance) should be closely monitored and evaluated, to inform any associated refinements and to develop an in-depth understanding of the process and outcomes associated with embedding routine measurement in practice. Further work is also required to identify an alternative OMI or adapt the SWEMWBS for appropriate use with children under the age of.   11.

Foundations UK: 2025. 106p.

Trends in Drug Driving Charges, Roadside Drug Testing and Drug Use in NSW, 2008-2023 

By Adam Teperski, Stewart Boiteux, and Callan Brown

Aim: To examine trends in drug driving charges, roadside drug testing, and population drug use in New South Wales (NSW) between 2008 and 2023. METHOD Data on drug driving proceedings and roadside drug testing were obtained from the NSW Police Force. Focusing on the period between 2008 and 2023, we describe trends in the number of drug driving charges laid by police, as well as changes in the volume of roadside drug tests undertaken by police and the detection rate over time. We also examine the profile of drivers who are proceeded against after testing positive and any differences in key characteristics over time. Finally, to support the interpretation of these results, we assess changes in drug use from two population drug use monitoring systems and consider associated trends in self-reported drug driving behaviours. RESULTS Between 2008 and 2023, the number of drug driving charges rose from an average of 102 per quarter in 2008 to 3,296 in 2023. This significant growth in charges followed the announcement of two expansions of the NSW Mobile Drug Testing (MDT) program, which resulted in a rapid increase in testing volumes from around 20,000 to 156,000 tests per year in 2008 and 2019 respectively. While the MDT expansions aimed to increase police capacity to detect and deter drug driving behaviours, we found a weak relationship between total testing volumes and subsequent detection rates, with the average detection rate varying between 2% and 18%. This suggests that the number of drug driving charges over this 15-year period was not simply a function of the number of tests conducted, but also related to when, where, and for whom tests were used. When we compared drug driving offenders charged in 2019 with those charged in 2023, we found that the 2023 cohort were more likely to be older, test positive for methamphetamine, reside in regional areas and have a prior drug driving charge. During the period we study, population-level drug use has remained relatively consistent. Meanwhile, the self-reported prevalence of drug driving has decreased at a steady rate, with this downward trend commencing prior to the start of the MDT program in NSW. CONCLUSION Sequential expansions of the MDT program have led to a considerable increase in the number of offenders charged with drug driving offences in NSW between 2008 and 2023. Recent growth in the roadside drug test detection rate and subsequent charges may be driven by police targeting of repeat drug driving offenders, and motorists who offend in regional areas. 

Bureau Brief, No. 172 Sydney, NSW: NSW Bureau of Crime  Statistics and Research. ....2024. 23p.

20-Year Trends in Australian Methamphetamine-Related Deaths, 2001–2020

By Oisin Stronach, Paul Dietze, Michael Livingston, Amanda Roxburgh

Background

Over the past two decades methamphetamine-related harms have increased in Australia. Previous analysis of methamphetamine-related deaths has covered limited timeframes, and largely focused on drug-toxicity deaths. This paper examines long-term trends in methamphetamine-related deaths over 20 years, including deaths due to a range of specific causes.

Methods

Descriptive analyses were conducted on Australian methamphetamine-related deaths (2001–2023) by cause, extracted from the National Coronial Information System, an online database containing deaths reported to coroners in Australia and New Zealand. Joinpoint trend analyses were used to assess changes over time between 2001 and 2020 (with data from 2021 to 2023 likely incomplete and thus excluded).

Results

Unintentional drug toxicity was the cause of 49.8 % of methamphetamine-related deaths, intentional self-harm (including toxicity) 23.3 %, unintentional injury 15.1 %, natural causes 9.6 %, and assaults 2.3 %. Between 2001 and 2020, joinpoint analysis showed three trend change points among all-cause methamphetamine-related mortality rates, resulting in four distinct periods: two periods where they increased (2001–2006 – annual percentage change (APC) = 15.4 %; 2009–2016 – APC 25.5 %), and two where they decreased (2006–2009 – APC = –11.8 %; 2017–2020 – APC = –2.9 %). Similar patterns were evident among rates of intentional self-harm and unintentional injury. Deaths caused by unintentional drug toxicity saw two trend change points (2011, 2016), and rates increased across all three periods. Natural cause deaths had three trend change points (2007, 2010, 2015), and rates continued to rise after 2015, largely driven by increases in circulatory diseases.

Conclusion

Cause-specific models highlighted diverse trends. Recent trends show unintentional drug toxicity deaths have slightly increased, intentional self-harm stabilised, and unintentional injury and assault deaths have declined. Deaths from natural causes involving methamphetamine continued to increase, highlighting a public health concern and a potential need for early circulatory disease screening among people who use methamphetamine.

International Journal of Drug Policy Volume 131, September 2024, 104548